FrancophonIA/ELRC3.0 huggingface dataset:
English: Inject your dose
Croatian: Injicirajte svoju dozu
English: • Inflamed stomach (gastritis).
Croatian: • Upala želuca (gastritis).
English: Always use this medicine exactly as your doctor has told you.
Croatian: Kako primjenjivati lijek Victoza Uvijek primijenite ovaj lijek točno onako kako Vam je rekao liječnik.
English: Tap the cartridge gently with your finger a few times.
Croatian: Nekoliko puta lagano kucnite prstom po ulošku.
English: Animal studies did not indicate direct harmful effects with respect to fertility but slightly increased early embryonic deaths at the highest dose.
Croatian: Ispitivanja na životinjama nisu ukazala na izravne štetne učinke na fertilitet osim blago povišene stope rane smrti embrija pri najvišoj dozi.
English: Keep away from the freezer compartment.
Croatian: Čuvati dalje od odjeljka za zamrzavanje.
English: After first use of the pen, store below 30°C or in a refrigerator.
Croatian: Nakon prve primjene brizgalicu čuvati na temperaturi ispod 30°C ili u hladnjaku.
English: • A severe form of allergic reaction (anaphylactic reaction) with additional symptoms such as breathing problems, swelling of throat and face, fast heartbeat, etc.
Croatian: • Težak oblik alergijske reakcije (anafilaktička reakcija) s dodatnim simptomima kao što su problemi s disanjem, oticanje grla i lica, ubrzani otkucaji srca itd.
English: Both improvement of glycaemic control and reduction of cardiovascular morbidity and mortality are an integral part of the treatment of type 2 diabetes.
Croatian: I poboljšanje regulacije glikemije i smanjenje kardiovaskluarnog morbiditeta i mortaliteta sastavni su dio liječenja šećerne bolesti tipa 2.
English: None of the patients reported severe hypoglycaemia.
Croatian: Niti jedan bolesnik nije prijavio tešku hipoglikemiju.
English: Following subcutaneous administration, the protracted action profile is based on three mechanisms: self-association, which results in slow absorption; binding to albumin; and higher enzymatic stability towards the dipeptidyl peptidase -4 (DPP-4) and neutral endopeptidase (NEP) enzymes, resulting in a long plasma half-life.
Croatian: Nakon supkutane primjene, profil produljenog djelovanja zasniva se na tri mehanizma: samoudruživanje, što dovodi do polagane apsorpcije; vezanje za albumin i viša enzimatska stabilnost prema enzimima dipeptidil peptidazi-4 (DPP-4) i neutralnoj endopeptidazi
English: Victoza is used on its own if your blood sugar is not properly controlled by diet and exercise alone, and you cannot use metformin (another diabetes medicine).
Croatian: Victoza se koristi samostalno ako ne postižete dobru kontrolu šećera u krvi samo dijetom i tjelovježbom, a ne možete uzimati metformin (drugi lijek za šećernu bolest).
English: even if their signs of illness are the same as yours.
Croatian: Može im naškoditi, čak i ako su njihovi znakovi bolesti jednaki Vašima.
English: • Postprandial glucose
Croatian: • Postprandijalna glukoza
English: The urine and faeces radioactivity was mainly excreted during the first 68 days, and corresponded to three minor metabolites, respectively.
Croatian: Radioaktivnost se u mokraći i stolici uglavnom izlučivala tijekom prvih 6-8 dana, a odgovarala je trima manjim metabolitima.
English: INSTRUCTIONS FOR USING THE VICTOZA PEN Please read these instructions carefully before using your pen.
Croatian: Prije uporabe brizgalice pozorno pročitajte ove upute.
English: The best places to give yourself the injection are the front of your thighs, the front of your waist (abdomen), or your upper arm.
Croatian: Najbolja mjesta za davanje injekcija su prednja strana bedara, područje trbuha (abdomen) ili nadlaktica.
English: Pull off the outer needle cap and keep it for later.
Croatian: Skinite vanjski zatvarač igle i sačuvajte ga za poslije.
English: If the dose selector stops before your needed dose lines up with the pointer, there is not enough liraglutide left for a full dose.
Croatian: Ako se izbornik doze zaustavi prije negoli se potrebna doza poravnala s pokazivačem, to znači da nije ostalo dovoljno liraglutida za cijelu dozu.
English: Pharmacokinetic properties were assessed in clinical studies in the paediatric population with type 2 diabetes aged 10 years and above.
Croatian: Farmakokinetička svojstva ocjenjivana su u kliničkim ispitivanjima u pedijatrijskoj populaciji sa šećernom bolešću tipa 2 u dobi od 10 i više godina.
English: The most frequently reported adverse reactions during clinical trials were gastrointestinal disorders: nausea and diarrhoea were very common, whereas vomiting, constipation, abdominal pain, and dyspepsia were common.
Croatian: Najčešće prijavljene nuspojave tijekom kliničkih ispitivanja bile su gastrointestinalni poremećaji: mučnina i proljev bili su vrlo česti, dok su povraćanje, konstipacija, bol u abdomenu i dispepsija bili česti.
English: Clinical trials with liraglutide indicate improved beta-cell function based on measures such as the homeostasis model assessment for beta-cell function (HOMA-B) and the proinsulin to insulin ratio.
Croatian: Klinička ispitivanja liraglutida pokazuju poboljšanu funkciju beta stanica na osnovi parametara poput procjene modela homeostaze za funkciju beta stanica (HOMA-B) te omjera proinzulina i inzulina.
English: Population pharmacokinetic analysis suggests that body mass index (BMI) has no significant effect on the pharmacokinetics of liraglutide.
Croatian: Populacijska farmakokinetička analiza ukazuje na to da indeks tjelesne mase (ITM) nema značajnog učinka na farmakokinetiku liraglutida.
English: MedDRA system organ classes
Croatian: MedDRA klasifikacija organskih sustava
English: During the 26 weeks, there were 12 serious events in 235 patients (5.1%) using liraglutide, whereas there were 6 serious adverse events in 232 patients (2.6%) using exenatide.
Croatian: Tijekom 26 tjedana, bilo je 12 ozbiljnih štetnih događaja u 235 bolesnika (5,1%) koji su liječeni liraglutidom, u odnosu na 6 ozbiljnih štetnih događaja u 232 bolesnika (2,6%) koji su liječeni eksenatidom.
English: Consistent with the potentially immunogenic properties of medicinal products containing proteins or peptides, patients may develop anti-liraglutide antibodies following treatment with liraglutide.
Croatian: Sukladno mogućim imunogenim svojstvima lijekova koji sadrže proteine ili peptide, u bolesnika se tijekom liječenja liraglutidom mogu razviti protutijela na liraglutid.
English: Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Croatian: Unutar svake grupe učestalosti nuspojave su prikazane u padajućem nizu prema ozbiljnosti.
English: The primary endpoint was the time from randomisation to first occurrence of any major adverse cardiovascular events (MACE): CV death, non-fatal myocardial infarction or non-fatal stroke.
Croatian: Primarna mjera ishoda bilo je vrijeme od randomizacije do prvog nastupa bilo kojeg velikog kardiovaskularnog štetnog događaja (engl. major adverse cardiovascular events, MACE): smrti uzrokovane KV događajem, infarkta miokarda bez smrtnog ishoda ili moždanog udara bez smrtnog ishoda.
English: This medicine should not be used if you have type 1 diabetes (your body does not produce any insulin) or diabetic ketoacidosis (a complication of diabetes with high blood sugar and increase in effort to breathe).
Croatian: Ovaj lijek ne smijete primjenjivati ako imate šećernu bolest tipa 1 (tijelo uopće ne stvara inzulin) ili dijabetičku ketoacidozu (komplikacija šećerne bolesti s visokim šećerom u krvi i pojačanim naporom pri disanju).
English: A large cardiovascular outcomes trial (the LEADER trial) was also conducted with liraglutide in 9,340 patients with type 2 diabetes mellitus at high cardiovascular risk.
Croatian: Provedeno je i veliko ispitivanje kardiovaskularnih ishoda (ispitivanje LEADER) s liraglutidom u 9340 bolesnika sa šećernom bolešću tipa 2 i visokim kardiovaskularnim rizikom.
English: Liraglutide exposure increased proportionally with dose.
Croatian: Izloženost liraglutidu rasla je proporcionalno dozi.
English: Antibody formation has not been associated with reduced efficacy of liraglutide.
Croatian: Stvaranje protutijela nije udruženo sa smanjenom djelotvornosti liraglutida.
English: There was no consistent pattern with respect to system organ class of events.
Croatian: Nije bilo dosljednosti s obzirom na klasifikaciju organskih sustava.
English: Overall, frequency, type and severity of adverse reactions in adolescents and children aged 10 years and above were comparable to that observed in the adult population.
Croatian: Sveukupno, učestalost, vrsta i težina nuspojava u adolescenata i djece u dobi od 10 ili više godina bile su usporedive s onima opaženima u odrasle populacije.
English: The GLP-1 receptor is the target for native GLP-1, an endogenous incretin hormone that potentiates glucose-dependent insulin secretion from the pancreatic beta cells.
Croatian: GLP-1 receptor je ciljno mjesto za nativni GLP-1, endogeni inkretinski hormon koji pojačava o glukozi ovisno lučenje inzulina iz beta stanica gušterače.
English: A drop of liraglutide should appear at the needle tip.
Croatian: Kapljica liraglutida trebala bi se pojaviti na vrhu igle.
English: In the LEADER trial, microvascular events comprised nephropathy and retinopathy outcomes.
Croatian: U ispitivanju LEADER mikrovaskularne događaje činili su ishodi nefropatije i retinopatije.
English: Skin and subcutaneous tissue disorder
Croatian: Poremećaji kože i potkožnog tkiva
English: Pancreatitis was also reported from marketed use.
Croatian: Pankreatitis je prijavljen i nakon stavljanja lijeka na tržište.
English: Patients treated with liraglutide should be advised of the potential risk of dehydration in relation to gastrointestinal side effects and take precautions to avoid fluid depletion.
Croatian: Bolesnike liječene liraglutidom treba upozoriti na mogući rizik dehidracije zbog gastrointestinalnih nuspojava i na to da poduzmu mjere opreza kako bi izbjegli gubitak tekućine.
English: Acute pancreatitis
Croatian: Akutni pankreatitis
English: Description of selected adverse reactions
Croatian: Opis odabranih nuspojava
English: A clinically relevant interaction with active substances with poor solubility or with narrow therapeutic index such as warfarin cannot be excluded.
Croatian: Ne može se isključiti klinički značajna interakcija s djelatnim tvarima slabe topljivosti ili uskog terapijskog indeksa kao što je varfarin.
English: Primary outcome or vital status at end of trial was available for 99.7% and 99.6% of participants randomised to liraglutide and placebo, respectively.
Croatian: Podaci o primarnom ishodu ili vitalnom statusu na kraju ispitivanja bili su dostupni za 99,7% sudionika liječenih liraglutidom i 99,6% onih koji su primali placebo.
English: You may only split your dose between your current pen and a new pen if trained or advised by your healthcare professional.
Croatian: Dozu možete razdijeliti između sadašnje i nove brizgalice, samo ako ste za to obučeni ili su Vas tako savjetovali Vaš liječnik ili medicinska sestra.
English: Treatment with liraglutide alone and in combination with one or two oral antidiabetic drugs resulted in a reduction in fasting plasma glucose of 13-43.5 mg/dl (0.72-2.42 mmol/l).
Croatian: Liječenje liraglutidom primijenjenim samostalno i u kombinaciji s jednim ili dvama oralnim antidijabeticima rezultiralo je sniženjem glukoze u plazmi natašte od 13-43,5 mg/dl (0,72-2,42 mmol/l).
English: Dose adjustments of griseofulvin and other compounds with low solubility and high permeability are not required.
Croatian: Nije potrebno prilagođavanje doze grizeofulvina i drugih tvari niske topljivosti i visoke permeabilnosti.
English: You can keep the pen for 1 month when stored at a temperature below 30˚C or in a refrigerator (2˚C8˚C), away from the freezer compartment.
Croatian: Brizgalicu možete koristiti mjesec dana ako je čuvate na temperaturi ispod 30°C ili u hladnjaku (2°C-8°C), dalje od odjeljka za zamrzavanje.
English: After that, you may see a drop liraglutide at the needle tip.
Croatian: Nakon toga možete vidjeti kapljicu liraglutida na vrhu igle.
English: When initiating treatment with Victoza, you may in some cases experience loss of fluids/dehydration, e.g. in case of vomiting, nausea and diarrhoea.
Croatian: Pri započinjanju liječenja lijekom Victoza u nekim slučajevima možete osjetiti gubitak tekućine/dehidraciju, primjerice u slučaju povraćanja, mučnine i proljeva.
English: Do not use this medicine if the solution is not clear and colourless or almost colourless.
Croatian: Ovaj lijek se ne smije upotrijebiti ako otopina nije bistra i bezbojna ili gotovo bezbojna.
English: The analysis of time to first microvascular event for liraglutide vs placebo had a HR of 0.84 [0.73, 0.97].
Croatian: U analizi vremena do prvog mikrovaskularnog događaja uz liraglutid u odnosu na placebo HR je iznosio 0,84 [0,73; 0,97].
English: No dose adjustment is required for adolescents and children aged 10 years and above.
Croatian: Nije potrebno prilagođavanje doze u adolescenata i djece u dobi od 10 ili više godina.
English: • Painful or swollen tummy (abdomen)
Croatian: • Bolan ili otečen trbuh (abdomen)
English: There was no clinically relevant effect on the overall exposure of either ethinyloestradiol or levonorgestrel.
Croatian: Nije bilo klinički značajnog učinka na ukupnu izloženost etinilestradiolu ili levonorgestrelu.
English: Dosing with Victoza during mid-gestation caused a reduction in maternal weight and foetal growth with equivocal effects on ribs in rats and skeletal variation in the rabbit.
Croatian: Doziranje lijeka Victoza tijekom srednjeg gestacijskog razdoblja uzrokovalo je smanjenje majčine težine i fetalnog rasta, uz dvosmislene učinke na rebra kod štakora te skeletne promjene u kunića.
English: Victoza is supplied as a clear, and colourless or almost colourless, solution for injection in a pre-filled pen.
Croatian: Victoza je bistra i bezbojna ili gotovo bezbojna otopina za injekciju u napunjenoj brizgalici.
English: Non-clinical studies have shown a treatment-related reduction of neonatal growth in suckling rat pups (see section 5.3).
Croatian: Neklinička ispitivanja pokazala su s liječenjem povezano smanjenje neonatalnog rasta u dojene mladunčadi štakora (vidjeti dio 5.3).
English: 2D barcode carrying the unique identifier included.
Croatian: 17. JEDINSTVENI IDENTIFIKATOR - 2D BARKOD Sadrži 2D barkod s jedinstvenim identifikatorom.
English: On the basis of the scientific conclusions for liraglutide the CHMP is of the opinion that the benefitrisk balance of the medicinal product(s) containing liraglutide is unchanged subject to the proposed changes to the product information
Croatian: Na temelju znanstvenih zaključaka za liraglutid, CHMP smatra da je omjer koristi i rizika lijeka(ova) koji sadrži(e) liraglutid nepromijenjen, uz predložene izmjene informacija o lijeku.
English: Most episodes were mild to moderate and occurred in a dose-dependent fashion.
Croatian: Većina tih epizoda bile su blage do umjerene i bile su ovisne o dozi.
English: • Gastro-oesophageal reflux disease (GORD).
Croatian: • Gastroezofagealna refluksna bolest (GERB).
English: 1all patients; 2previous OAD monotherapy; 3previous diet treated patients 5Victoza add-on to SGLT2i was investigated at all approved doses of SGLT2i 4the dosing of insulin glargine was open-labelled and was applied according to Guideline for titration of insulin glargine.
Croatian: 1svi bolesnici; 2prethodna monoterapija OAD-om; 3bolesnici prethodno liječeni dijetom 5Lijek Victoza kao dodatak inhibitoru SGLT2 ispitivan je u svim odobrenim dozama inhibitora SGLT2 4 doziranje glargin inzulina bilo je otvorenog tipa i primjenjivalo se prema Smjernicama za titriranje glargin inzulina.
English: NN:
Croatian: SN: NN:
English: • Bronchitis
Croatian: • Bronhitis
English: Victoza can be administered with needles up to a length of 8 mm and as thin as 32G.
Croatian: Victoza se može primjenjivati s iglama duljine do 8 mm i ne tanjim od 32G.
English: Pharmacotherapeutic group: Drugs used in diabetes, glucagon-like peptide-1 (GLP-1) analogues.
Croatian: Farmakoterapijska skupina: lijekovi za liječenje šećerne bolesti, analozi glukagonu sličnog peptida-1
English: • Your doctor may tell you to further increase the dose to 1.8 mg once a day, if your blood glucose is not adequately controlled with a dose of 1.2 mg.
Croatian: • Liječnik Vam može reći da povisite dozu na 1,8 mg jedanput na dan, ako se uz dozu od 1,2 mg nije postigla primjerena regulacija glukoze u krvi.
English: Dispose of it carefully and put the pen cap back on.
Croatian: Pažljivo je bacite u otpad i vratite zatvarač na brizgalicu.
English: Signs and symptoms of dehydration, including renal impairment and acute renal failure, have been reported in patients treated with liraglutide.
Croatian: Znakovi i simptomi dehidracije, uključujući oštećenje bubrega i akutno zatajenje bubrega, prijavljeni su u bolesnika liječenih liraglutidom.
English: When you are not using the pen, keep the pen cap on in order to protect from light.
Croatian: Kad brizgalicu ne koristite, zatvorite je zatvaračem brizgalice radi zaštite od svjetlosti.
English: It is not known whether liraglutide is excreted in human milk.
Croatian: Nije poznato izlučuje li se liraglutid u majčino mlijeko u ljudi.
English: On average, 8.6% of patients developed antibodies.
Croatian: Protutijela su se u prosjeku razvila u 8,6% bolesnika.
English: In the LEADER trial, (see subsection Cardiovascular evaluation), 873 patients were on premix insulin (with or without OAD(s)) at baseline and at least for the following 26 weeks.
Croatian: U ispitivanju LEADER (vidjeti odlomak 'Kardiovaskularna procjena') 873 bolesnika primala su predmiješani inzulin (u kombinaciji s oralnim antidijabeticima ili bez njih) na početku ispitivanja i najmanje sljedećih 26 tjedana.
English: • Allergic reactions like pruritus (itching) and urticaria (a type of skin rash)
Croatian: • Alergijske reakcije kao što su pruritus (svrbež) i koprivnjača (vrsta kožnog osipa)
English: Liraglutide did not reduce the plaque size of already established plaques.
Croatian: Liraglutid nije smanjio veličinu plaka već ustanovljenih plakova.
English: Caregivers must be very careful when handling used needles - to prevent needle injury and cross-infection.
Croatian: Osobe koje skrbe za bolesnika moraju biti osobito oprezne pri rukovanju rabljenim iglama kako bi spriječile ozljedu iglama i križnu infekciju.
English: • Microvascular evaluation
Croatian: • Procjena mikrovaskularnih događaja
English: Patients with mild and moderate renal impairment (creatinine clearance 60-90 ml/min and 3059 ml/min, respectively) may experience more gastrointestinal effects when treated with liraglutide.
Croatian: Bolesnici s blažim i umjerenim oštećenjem bubrega (klirens kreatinina 60-90 ml/min odnosno 30-59 ml/min) mogu imati više gastrointestinalnih učinaka uz liječenje liraglutidom.
English: Therefore, no dose adjustment of atorvastatin is required when given with liraglutide.
Croatian: Stoga nije potrebno prilagođavanje doze atorvastatina kad se uzima s liraglutidom.
English: Turn the dose selector until the flow check symbol lines up with the pointer.
Croatian: Okrećite izbornik doze dok se simbol za provjeru protoka ne poravna s pokazivačem.
English: Diabetic ketoacidosis has been reported in insulin-dependent patients after rapid discontinuation or dose reduction of insulin (see section 4.2).
Croatian: Dijabetička ketoacidoza prijavljena je u bolesnika ovisnih o inzulinu nakon brzog prekida ili smanjenja doze inzulina (vidjeti dio 4.2).
English: The risk of hypoglycaemia can be lowered by a reduction in the dose of sulfonylurea or insulin.
Croatian: Rizik od hipoglikemije može se smanjiti snižavanjem doze sulfonilureje ili inzulina.
English: Pull off the paper tab from a new disposable needle.
Croatian: Skinite papirnatu naljepnicu s nove jednokratne igle.
English: Generally, the patients reported severe nausea, vomiting and diarrhoea.
Croatian: Općenito, bolesnici su prijavili jaku mučninu, povraćanje i proljev.
English: Neonatal growth was reduced in rats while exposed to Victoza, and persisted in the post-weaning period in the high dose group.
Croatian: Neonatalni rast bio je smanjen u štakora tijekom izloženosti lijeku Victoza i to se zadržalo tijekom razdoblja nakon odvikavanja od sisanja u skupini na visokoj dozi lijeka.
English: Solution for injection.
Croatian: Otopina za injekciju.
English: In mouse models of atherosclerosis, liraglutide prevented aortic plaque progression and reduced inflammation in the plaque.
Croatian: U mišjim modelima ateroskleroze, liraglutid je spriječio progresiju plaka aorte i smanjio upalu u plaku.
English: The most frequent adverse reactions leading to withdrawal for liraglutide-treated patients were nausea (2.8% of patients) and vomiting (1.5%).
Croatian: Najčešće nuspojave koje su dovele do prestanka primjene lijeka u bolesnika liječenih liraglutidom bile su mučnina (2,8% bolesnika) i povraćanje (1,5%).
English: • Beta-cell function
Croatian: • Funkcija beta stanica
English: The safety profile of liraglutide in combination with premix insulin was overall comparable to that observed for placebo in combination with premix insulin (see section 4.8).
Croatian: Sigurnosni profil liraglutida u kombinaciji s predmiješanim inzulinom sveukupno je bio usporediv s onim koji je primijećen kod primjene placeba u kombinaciji s predmiješanim inzulinom (vidjeti dio 4.8).
English: • Increased pulse
Croatian: • Ubrzani puls
English: Use of liraglutide is not recommended in these patients since it is associated with transient gastrointestinal adverse reactions, including nausea, vomiting and diarrhoea.
Croatian: Primjena liraglutida se ne preporučuje u ovih bolesnika budući je povezana s prolaznim gastrointestinalnim nuspojavama uključujući mučninu, povraćanje i proljev.
English: The CHMP recommends that the terms of the marketing authorisation should be varied.
Croatian: CHMP predlaže izmjenu uvjeta odobrenja za stavljanje lijeka u promet.
English: Following a [3H]-liraglutide dose, intact liraglutide was not detected in urine or faeces.
Croatian: Nakon jedne doze [3H]-liraglutida nepromijenjeni liraglutid nije otkriven ni u mokraći niti u stolici.
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ BIOLOŠKE DJELATNE TVARI I PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE LIJEKA U PROMET
English: Diarrhoea may affect the absorption of concomitant oral medicinal products.
Croatian: Proljev može djelovati na apsorpciju istodobno uzetih oralnih lijekova.
English: Nasopharyngitis Bronchitis
Croatian: Nazofaringitis Bronhitis
English: • Cardiovascular evaluation
Croatian: • Kardiovaskularna procjena
English: Store in a refrigerator (2°C-8°C).
Croatian: Čuvati u hladnjaku (2°C-8°C).
English: Do not use this medicine after the expiry date which is stated on the pen label and carton after ‘EXP'.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na naljepnici brizgalice i kutiji iza oznake „Rok valjanosti“.
English: Inject the dose.
Croatian: Injicirajte dozu.
English: Very common Common Uncommon Rare
Croatian: Manje često Rijetko
English: The estimated hazard ratio was consistently below 1 for all 3 MACE components.
Croatian: Procijenjen omjer hazarda (engl. hazard ratio, HR) dosljedno je bio manji od 1 za sva 3 pojedinačna MACE događaja.
English: Some patients are expected to benefit from an increase in dose from 1.2 mg to 1.8 mg and based on clinical response, after at least one week, the dose can be increased to 1.8 mg to further improve glycaemic control.
Croatian: U nekih bolesnika povećanje doze sa 1,2 mg na 1,8 mg može biti korisno pa se prema kliničkom odgovoru doza može povisiti na 1,8 mg nakon najmanje jednog tjedna, kako bi se regulacija glikemije dodatno poboljšala.
English: Paediatric Population
Croatian: Pedijatrijska populacija
English: The mean clearance following subcutaneous administration of a single dose liraglutide is approximately 1.2 l/h with an elimination half-life of approximately 13 hours.
Croatian: Srednja vrijednost klirensa nakon supkutane primjene jedne doze liraglutida je otprilike 1,2 l/h, uz poluvijek eliminacije od otprilike 13 sati.